Amlodipine and Benazepril for High Blood Pressure

Amlodipine benazepril is a fixed-dose combination blood pressure medication that pairs two drugs with complementary mechanisms: amlodipine, a calcium channel blocker that relaxes blood vessel walls, and benazepril, an ACE inhibitor that reduces the hormone signals telling those vessels to tighten. Sold under the brand name Lotrel among others, the combination consistently lowers blood pressure more than either drug alone and comes with a side-effect profile that is, in some respects, better than what you’d expect from amlodipine by itself. The story behind why these two drugs were paired, and how the combination performs in real-world cardiovascular outcomes, is worth understanding if you or someone you know takes it.

How the Two Drugs Work Together

Amlodipine and benazepril attack high blood pressure through different pathways. Amlodipine blocks calcium from entering the smooth muscle cells lining your arteries, which prevents those muscles from contracting and lets the vessels relax and widen. Benazepril inhibits angiotensin-converting enzyme, which means your body produces less angiotensin II, a powerful chemical that narrows blood vessels and promotes salt and water retention. By hitting both pathways at once, the combination achieves blood pressure reductions that neither drug can manage on its own.

Pharmacokinetic studies in healthy volunteers have confirmed that the two drugs don’t interfere with each other’s absorption or metabolism. When given together versus separately, the blood levels and timing of peak concentration for both amlodipine and benazepril remain essentially unchanged.¹ This means combining them into a single capsule doesn’t alter how either drug behaves in your body. Each works as if it were given alone, but the blood pressure effects add up.

Blood Pressure Lowering

Multiple randomized trials have tested whether the combination actually outperforms either drug given solo, and the answer is consistently yes. In one placebo-controlled study, amlodipine 5 mg paired with benazepril 10 mg produced a response rate of about two thirds of patients, compared with half for amlodipine alone, roughly four in ten for benazepril alone, and about one in four for placebo.² Another trial confirmed that even at low doses, the combination delivers greater blood pressure drops than either monotherapy, with an excellent safety profile.³

The combination is particularly useful for people who haven’t responded well to a single drug. In a study of patients whose blood pressure remained uncontrolled on benazepril 40 mg alone, switching to amlodipine/benazepril brought average blood pressure down by about 17/14 mmHg over eight weeks, compared with just 5/7 mmHg for those who stayed on benazepril alone. About 80% of the combination group met the target diastolic blood pressure, versus 45% on benazepril monotherapy.⁴

These benefits also hold across racial and ethnic groups. A study specifically examining Black and White patients with hypertension not controlled on monotherapy found that the high-dose amlodipine-benazepril combination lowered both systolic and diastolic blood pressure significantly more than either drug alone in both populations.⁵ This matters because Black patients tend to have a blunted response to ACE inhibitors when used in isolation, but adding amlodipine restores robust blood pressure control.

Why the Combination Has Fewer Ankle-Swelling Problems

One of the most common complaints with amlodipine taken alone is ankle swelling. The drug widens the small arteries feeding your lower legs more than it widens the veins draining them, and this mismatch forces fluid into the surrounding tissue. This isn’t a sign of heart failure; it’s a local plumbing problem caused by the pressure imbalance in tiny blood vessels.

Adding benazepril partly fixes this imbalance. Because ACE inhibitors dilate both the arterial and venous sides of the circulation, they help even out the pressure difference that pushes fluid into the ankles. In one study that measured both ankle fluid volume and tissue pressure directly, amlodipine alone increased ankle fluid volume by about 17% and tissue pressure by roughly 57%. When benazepril was added, those increases shrank to about 6% and 21%, respectively. Clinically visible ankle swelling appeared in 11 patients on amlodipine alone but only 3 on the combination.⁶ Broader reviews confirm that adding any ACE inhibitor or angiotensin receptor blocker to a calcium channel blocker reduces peripheral edema in a dose-dependent way.⁷

This is one of the practical reasons the combination exists as a single pill. Ankle swelling from amlodipine is uncomfortable enough that many patients stop taking it, and losing blood pressure control is far more dangerous than the swelling itself. If the combination lets more people stay on treatment, the downstream cardiovascular benefit is real.

Cardiovascular Outcomes From the ACCOMPLISH Trial

Blood pressure numbers matter, but what really counts is whether a drug prevents heart attacks, strokes, and cardiovascular death. The largest trial to address this for amlodipine/benazepril was ACCOMPLISH, which enrolled over 11,000 high-risk patients with hypertension and randomly assigned them to either benazepril plus amlodipine or benazepril plus hydrochlorothiazide (a common diuretic). The trial was stopped early because the amlodipine combination was clearly winning. Patients on benazepril/amlodipine had about a 20% lower relative risk of the combined endpoint of cardiovascular death, heart attack, stroke, hospitalization for chest pain, cardiac arrest, or coronary revascularization. In absolute terms, about 9.6% of the amlodipine group had a primary event compared with 11.8% in the diuretic group.⁸

This result was striking because both groups achieved similar blood pressure levels, so the difference wasn’t simply about getting numbers lower. The implication was that the type of drugs you combine matters, not just the pressure you achieve. A cost-effectiveness analysis based on the ACCOMPLISH data later found that the amlodipine/benazepril regimen generated more quality-adjusted life years at a lower total cost than the hydrochlorothiazide/benazepril regimen, driven by fewer strokes and heart attacks.⁹

Kidney Protection and Metabolic Effects

People with diabetes often develop kidney damage that shows up as protein leaking into the urine. ACE inhibitors like benazepril are well known for slowing this process, but adding amlodipine raised questions early on: some older calcium channel blockers appeared to increase protein leakage. Studies with the amlodipine/benazepril combination have been reassuring. A trial comparing two ACE inhibitor/calcium channel blocker fixed-dose combinations found that both significantly reduced urinary albumin levels in patients with diabetic kidney disease.¹⁰

The metabolic picture extends beyond the kidneys. In a head-to-head trial against another common combination (valsartan/hydrochlorothiazide) in patients with type 2 diabetes, amlodipine/benazepril matched the competing regimen for blood pressure lowering but showed better preservation of kidney filtration rate, along with improvements in blood sugar control, triglycerides, HDL cholesterol, and uric acid levels.¹¹ These metabolic advantages probably stem from the benazepril component, since ACE inhibitors as a class tend to improve insulin sensitivity. A recent study found that benazepril significantly lowered insulin resistance scores over 12 months in hypertensive patients with insulin resistance.¹² For patients with both high blood pressure and metabolic concerns, the combination avoids the blood sugar and cholesterol problems that diuretics can sometimes cause.

The Adherence Advantage of a Single Pill

Taking one capsule instead of two sounds like a minor convenience, but the data on adherence tells a different story. People prescribed the fixed-dose amlodipine/benazepril capsule are measurably more likely to keep taking their medication than people prescribed the same two drugs as separate pills.

One study found an adherence rate of about 88% for the fixed-dose combination versus 69% for the separate-pill regimen.¹³ Another reported a medication possession ratio of about 81% for the single capsule versus 74% for the two-pill approach, with the fixed-dose group also using fewer medical resources overall.¹⁴ Among elderly patients specifically, the gap was even wider: about 63% compliance with the fixed-dose pill versus 49% with free-combination therapy.¹⁵

These differences matter because hypertension is a silent condition. You can’t feel whether your blood pressure is controlled, so there’s no symptom reminding you to take your pills. Every pill you skip is a period of uncontrolled blood pressure. Over years, those gaps accumulate into increased stroke and heart attack risk. Simplifying the regimen to one capsule daily removes one of the small friction points that cause people to fall off treatment.

Side Effects and What to Watch For

The combination is generally well tolerated, but the benazepril component introduces the possibility of a dry cough, which is the most distinctive side effect of any ACE inhibitor. In one trial comparing the fixed-dose combination to amlodipine alone as first-line treatment, about 11% of patients on the combination developed a cough compared with none in the amlodipine-only group.¹⁶ This cough is caused by the buildup of bradykinin, a substance that ACE normally breaks down. It’s annoying but not dangerous, and it goes away when the drug is stopped. For patients who can’t tolerate the cough, switching the benazepril component to an angiotensin receptor blocker is the standard workaround.

Other side effects typical of the individual components can still occur. Dizziness, headache, and flushing are possible from the amlodipine side. Because benazepril lowers angiotensin II levels, potassium levels can rise, so periodic blood work to check potassium and kidney function is standard practice. Both drugs lower blood pressure, which means the combination can occasionally cause lightheadedness when standing up quickly, particularly at higher doses or in older adults.

The benazepril component also carries a black-box warning against use during pregnancy. ACE inhibitors can cause serious harm to a developing fetus, including kidney damage and low amniotic fluid levels. Women who become pregnant while on this medication should contact their prescriber immediately.

Drug Interactions and Contraindications

Because the benazepril component affects kidney function and potassium balance, certain drug combinations demand caution. Non-steroidal anti-inflammatory drugs like ibuprofen or naproxen can blunt the blood-pressure-lowering effect and, when combined with an ACE inhibitor, increase the risk of kidney problems, particularly in people whose kidneys are already under stress.¹⁷ Potassium supplements and potassium-sparing diuretics can push potassium levels dangerously high when combined with an ACE inhibitor. There is also evidence linking ACE inhibitors with lithium toxicity in patients taking lithium for mood disorders.¹⁸

ACE inhibitors should not be combined with another class called direct renin inhibitors (like aliskiren) in patients with diabetes, because the combination raises the risk of dangerously low blood pressure, elevated potassium, and kidney failure. Patients with a history of angioedema, a rare but serious swelling reaction involving the face, throat, or tongue, should avoid all ACE inhibitors, including this combination.

Available Doses and Typical Prescribing

The fixed-dose capsule comes in several strengths, typically pairing amlodipine at 2.5, 5, or 10 mg with benazepril at 10, 20, or 40 mg. Prescribers usually start at a lower dose and adjust upward based on blood pressure response. In clinical trials, a common approach was to begin with amlodipine 5 mg/benazepril 10 or 20 mg and escalate after four weeks if needed.¹⁹ In one trial targeting patients unresponsive to benazepril alone, the protocol started at amlodipine 5 mg/benazepril 40 mg and forced titration up to amlodipine 10 mg/benazepril 40 mg after four weeks.²⁰

The capsule is taken once daily, which aligns with amlodipine’s long half-life of roughly 35 to 50 hours. This extended duration means even a slightly late dose doesn’t create a sharp gap in coverage, another practical advantage over shorter-acting combinations. Generic versions are widely available, which has brought the cost down considerably from the original branded product.

How It Fits Into Guideline Recommendations

Hypertension guidelines generally recommend combining drugs from two different classes when a single agent doesn’t get blood pressure to target, or as initial therapy when blood pressure is substantially elevated. The pairing of a calcium channel blocker with an ACE inhibitor is one of the preferred two-drug combinations across major guidelines. UK guidelines, for example, have long recommended adding a calcium channel blocker to an ACE inhibitor (or vice versa) as a logical step-up strategy, recognizing that the two classes complement each other physiologically.²¹

The ACCOMPLISH trial results strengthened the case for this pairing over the once-traditional ACE inhibitor plus diuretic combination, at least in high-risk patients. Whether this advantage extends to lower-risk populations is less clear, but the trial shifted prescribing patterns and guideline language in favor of the calcium channel blocker combination in many settings.

What Happens in an Overdose

Intentional or accidental overdose of amlodipine/benazepril can be life-threatening, primarily because of severe drops in blood pressure and heart rate. A published case report describes a patient who ingested 200 mg of amlodipine and 400 mg of benazepril in a suicide attempt. Despite aggressive treatment including large volumes of intravenous fluids, multiple blood-pressure-raising medications at high doses, and high-dose insulin therapy, the patient’s cardiovascular system continued to deteriorate, progressing to cardiac arrest. The addition of angiotensin II as a rescue medication ultimately stabilized blood pressure and allowed the other drugs to be tapered.²²

This case underscores both the danger of calcium channel blocker overdose and the evolving treatment landscape. Amlodipine overdose in particular is notoriously difficult to manage because the drug’s long half-life means toxicity persists for days. Emergency treatment typically involves activated charcoal if the patient presents early, followed by calcium infusions, vasopressors, and high-dose insulin with glucose. The use of synthetic angiotensin II, approved by the FDA in 2017 for refractory shock, represents a newer option that directly counteracts the loss of angiotensin II signaling caused by benazepril overdose while supporting vascular tone against amlodipine’s effects.

Who Should Think Twice

Beyond the pregnancy contraindication and the angioedema risk already mentioned, a few patient groups need extra consideration. People with severe aortic stenosis (a narrowed heart valve) can be sensitive to the blood-pressure-lowering effects of amlodipine and may develop dangerously low pressures. Patients with significant kidney impairment need dose adjustments and close monitoring, because benazepril is cleared through the kidneys and can worsen function in already-compromised organs, particularly when blood flow to the kidneys depends heavily on the angiotensin system.

Older adults with isolated systolic hypertension, where only the top number is elevated, are actually a group that tends to do well on this combination, since both amlodipine and ACE inhibitors are effective against systolic pressure. The adherence data in elderly patients, while showing lower absolute rates than younger populations, still favors the fixed-dose pill over separate tablets. The practical takeaway for older adults is that the simplified regimen is worth discussing with a prescriber, particularly when multiple medications are already in the mix and every additional pill increases the chance of one being forgotten.